121 related articles for article (PubMed ID: 38133526)
1. Potential role of Fibrosis-4 score in hepatocellular carcinoma screening: The Kangbuk Samsung Health Study.
Shin S; Sohn W; Chang Y; Cho Y; Kwon MJ; Wild SH; Byrne CD; Ryu S
Hepatol Res; 2024 Jun; 54(6):551-561. PubMed ID: 38133526
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
3. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
4. A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus.
Cong M; Ou X; Huang J; Long J; Li T; Liu X; Wang Y; Wu X; Zhou J; Sun Y; Shang Q; Chen G; Ma H; Xie W; Piao H; Yang Y; Gao Z; Xu X; Tan Z; Chen C; Zeng N; Wu S; Kong Y; Liu T; Wang P; You H; Jia J; Zhuang H
OMICS; 2020 Jul; 24(7):415-423. PubMed ID: 32522092
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma Multidisciplinary Clinic-Cairo University (HMC-CU) score: A new simple score for diagnosis of HCC.
Abdelaziz AO; Nabil MM; Omran DA; Abdelmaksoud AH; Asem N; Shousha HI; Elbaz TM; Leithy R
Arab J Gastroenterol; 2020 Jun; 21(2):102-105. PubMed ID: 32439235
[TBL] [Abstract][Full Text] [Related]
6. Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B.
Liang LY; Lee HW; Wong VW; Yip TC; Tse YK; Hui VW; Lui GC; Chan HL; Wong GL
Clin Mol Hepatol; 2021 Jul; 27(3):499-509. PubMed ID: 33631920
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
8. The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis.
Guan MC; Zhang SY; Ding Q; Li N; Fu TT; Zhang GX; He QQ; Shen F; Yang T; Zhu H
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769597
[TBL] [Abstract][Full Text] [Related]
9. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
[TBL] [Abstract][Full Text] [Related]
10. Application of the Multi-Omics Liquid Biopsy Method M2P-HCC in Early Liver Cancer Screening for High-Risk Individuals with Hepatitis B-Related Liver Cancer.
Yu X; Lei X
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568847
[TBL] [Abstract][Full Text] [Related]
11. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
Marrero JA; Su GL; Wei W; Emick D; Conjeevaram HS; Fontana RJ; Lok AS
Hepatology; 2003 May; 37(5):1114-21. PubMed ID: 12717392
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genetic factors associated with fatty liver disease-related hepatocellular carcinoma.
Kogiso T; Ogasawara Y; Horiuchi K; Taniai M; Tokushige K
Cancer Med; 2023 Sep; 12(17):17798-17807. PubMed ID: 37644826
[TBL] [Abstract][Full Text] [Related]
13. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.
Best J; Bechmann LP; Sowa JP; Sydor S; Dechêne A; Pflanz K; Bedreli S; Schotten C; Geier A; Berg T; Fischer J; Vogel A; Bantel H; Weinmann A; Schattenberg JM; Huber Y; Wege H; von Felden J; Schulze K; Bettinger D; Thimme R; Sinner F; Schütte K; Weiss KH; Toyoda H; Yasuda S; Kumada T; Berhane S; Wichert M; Heider D; Gerken G; Johnson P; Canbay A
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):728-735.e4. PubMed ID: 31712073
[TBL] [Abstract][Full Text] [Related]
14. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
Sarwar S; Khan AA; Tarique S
J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
[TBL] [Abstract][Full Text] [Related]
15. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma.
Zhu W; Shi P; Liang A; Zhu Y; Fu J; Yuan S; Wu X
BMC Cancer; 2022 Oct; 22(1):1061. PubMed ID: 36241994
[TBL] [Abstract][Full Text] [Related]
16. Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm.
Tayob N; Lok AS; Do KA; Feng Z
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):469-475.e2. PubMed ID: 26260109
[TBL] [Abstract][Full Text] [Related]
17. Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agents.
Hsu WF; Lai HC; Chuang PH; Su WP; Chen SH; Chen HY; Wang HW; Huang GT; Peng CY
J Viral Hepat; 2022 Sep; 29(9):785-794. PubMed ID: 35657121
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
19. Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Azuma S; Asahina Y; Kakinuma S; Azuma K; Miyoshi M; Inoue E; Tsunoda T; Sato A; Kaneko S; Nagata H; Kawai-Kitahata F; Murakawa M; Nitta S; Itsui Y; Tomita M; Nakagawa M; Watanabe M
Dig Dis; 2019; 37(3):247-254. PubMed ID: 30625487
[TBL] [Abstract][Full Text] [Related]
20. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.
Poynard T; Lacombe JM; Deckmyn O; Peta V; Akhavan S; de Ledinghen V; Zoulim F; Samuel D; Mathurin P; Ratziu V; Thabut D; Housset C; Fontaine H; Pol S; Carrat F
JHEP Rep; 2021 Aug; 3(4):100298. PubMed ID: 34142073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]